Urinary proteomic analysis of chronic allograft nephropathy

Proteomics - Clinical Applications

Volumn 2, Issue 7-8, 2008, Pages 1025-1035

  O'Riordan, Edmond ^a,b   Orlova, Tatyana N ^b   Mendelev, Natalia ^b   Patschan, Daniel ^b   Kemp, Rowena ^a   Chander, Praveen N ^b   Hu, Rena ^b   Hao, Gang ^c   Gross, Steven S ^c   Iozzo, Renato V ^d   Delaney, Veronica ^b   Goligorsky, Michael S ^b  

^a SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c WEILL CORNELL MEDICAL CENTER   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Chronic allograft nephropathy; Kidney; Transplant; Urine

Indexed keywords

ALPHA 1 MICROGLOBULIN; BETA 2 MICROGLOBULIN; ENDOREPELLIN; PERLECAN; PREALBUMIN; PROTEOGLYCAN; PROTEOME;

ARTICLE; BANFF CLASSIFICATION; CARBOXY TERMINAL SEQUENCE; CHRONIC ALLOGRAFT NEPHROPATHY; CLASSIFICATION ALGORITHM; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT RECIPIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; URINALYSIS;

EID: 50849117844     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200780137     Document Type: Article

References (45)

1. Hariharan, S., Johnson, C. P., Bresnahan, B. A., Taranto, S. E. et al., Improved graft survival after renal transplantation in the United States, 1988 to 1996. N. Engl. J. Med. 2000, 342, 605-612.
2. Racusen, L. C., Solez, K., Colvin, R. B., Bonsib, S. M. et al., The Banff 97 working classification of renal allograft pathology. Kidney Int. 1999, 55, 713-723.
3. Schwarz, A., Mengel, M., Gwinner, W., Radermachar, J. et al., Risk factors for chronic allograft nephropathy after renal transplantation: A protocol biopsy study. Kidney Int. 2005, 67, 341-348.
4. Legendre, C., Thervet, E., Skhiri, H., Mamzer-Bruneel, M. F. et al., Histologic features of chronic allograft nephropathy revealed by protocol biopsies in kidney transplant recipients. Transplantation 1998, 65, 1506-1509.
5. Nankivell, B. J., Borrows, R. J., Fung, C. L., O'Connell, P. J. et al., The natural history of chronic allograft nephropathy. N. Engl. J. Med. 2003, 349, 2326-2333.
6. Hayry, P., Paavonen, T., Taskinen, E., Tomlanovich, E. et al., Protocol core needle biopsy and histological chronic allograft damage index as surrogate endpoint for long-term graft survival. Transplant Proc. 2004, 36, 89-91.
7. Seron, D., Moreso, F., Protocol biopsies and risk factors associated with chronic allograft nephropathy. Transplant Proc. 2002, 34, 331-332.
8. Schaub, S., Wilkins, J., Weiler, T., Sangster, K. et al., Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry. Kidney Int. 2004, 65, 323-332.
9. Tencer, J., Thysell, H., Andersson, K., Grubb, A. Stability of albumin, protein HC, immunoglobulin G, kappa- and lambda-chain immunoreactivity, orosomucoid and alpha 1-antitrypsin in urine stored at various conditions. Scand. J. Clin. Lab. Invest. 1994, 54, 199-206.
10. O'Riordan, E., Orlova, T. N., Mei, J. J., Butt, K. et al., Bioinformatic analysis of the urine proteome of acute allograft rejection. J. Am. Soc. Nephrol. 2004, 15, 3240-3248.
11. Coombes, K. R., Fritsche, H. A., Jr., Clarke, C., Chen, J. N. et al., Quality control and peak finding for proteomics data collected from nipple aspirate fluid by surface-enhanced laser desorption and ionization. Clin. Chem. 2003, 49, 1615-1623.
12. Izmirlian, G., Application of the random forest classification algorithm to a SELDI-TOF proteomics study in the setting of a cancer prevention trial. Ann. N. Y. Acad. Sci. 2004, 1020, 154-174.
13. Qu, Y., Adam, B. L., Yasui, Y., Ward, M. D. et al., Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients. Clin. Chem. 2002, 48, 1835-1843.
14. Bix, G., Fu, J., Gonzalez, E. M., Macro, L. et al., Endorepellin causes endothelial cell disassembly of actin cytoskeleton and focal adhesions through alpha2beta1 integrin. J. Cell Biol. 2004, 166, 97-109.
15. Antus, B., Yao, Y., Song, E., Liu, S. et al., Opposite effects of testosterone and estrogens on chronic allograft nephropathy. Transpl. Int. 2002, 15, 494-501.
16. Freese, P., Svalander, C. T., Molne, J., Norden, G. et al., Chronic allograft nephropathy-biopsy findings and outcome. Nephrol. Dial. Transplant. 2001, 16, 2401-2406.
17. Isoniemi, H., Taskinen, E., Hayry, P., Histological chronic allograft damage index accurately predicts chronic renal allograft rejection. Transplantation 1994, 58, 1195-1198.
18. Iozzo, R. V., Matrix proteoglycans: From molecular design to cellular function. Annu. Rev. Biochem. 1998, 67, 609-652.
19. Mongiat, M., Sweeney, S. M., San Antonio, J. D., Fu, J. et al., Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan. J. Biol. Chem. 2003, 278, 4238-4249.
20. Cornell, L. D., Colvin, R. B., Chronic allograft nephropathy. Curr. Opin. Nephrol. Hypertens. 2005, 14, 229-234.
21. Mauiyyedi, S., Pelle, P. D., Saidman, S., Collins, A. B. et al., Chronic humoral rejection: Identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J. Am. Soc. Nephrol. 2001, 12, 574-582.
22. Randhawa, P. S., Finkelstein, S., Scantlebury, V., Shapiro, R. et al., Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation 1999, 67, 103-109.
23. Hueso, M., Alia, P., Moreso, F., Beltran-Sastre, V. et al., Angiotensin converting enzyme genotype and chronic allograft nephropathy in protocol biopsies. J. Am. Soc. Nephrol. 2004, 15, 2229-2236.
24. Dimeny, E., Tufveson, G., Lithell, H., Larsson, E. et al., The influence of pretransplant lipoprotein abnormalities on the early results of renal transplantation. Eur. J. Clin. Invest. 1993, 23, 572-579.
25. Nankivell, B. J., Fenton-Lee, C. A., Kuypers, D. R., Cheung, E. et al., Effect of histological damage on long-term kidney transplant outcome. Transplantation 2001, 71, 515-523.
26. Seron, D., Moreso, F., Fulladosa, X., Hueso, M. et al., Reliability of chronic allograft nephropathy diagnosis in sequential protocol biopsies. Kidney Int. 2002, 61, 727-733.
27. Sousa, M. M., Norden, A. G. W, Jacobsen, C, Willnow, T. E. et al., Evidence for the role of Megalin in renal uptake of transthyretin. J. Biol. Chem. 2000, 275, 38176-38181.
28. Tormey, W. P., O'Brien, P. A., Clinical associations of an increased transthyretin band in routine serum and urine protein electrophoresis. Ann. Clin. Biochem. 1993, 30, 550-554.
29. Saraiva, M. J., Costa, P. P., Goodman, D. S., Biochemical marker in familial amyloidotic polyneuropathy, Portuguese type. Family studies on the transthyretin (prealbumin)-methionine-30 variant. J. Clin. Invest. 1985, 76, 2171-2177.
30. Sousa, M. M., Norden, A. G., Jacobsen, C., Willnow, T. E. et al., Evidence for the role of megalin in renal uptake of transthyretin. J. Biol. Chem. 2000, 275, 38176-38181.
31. Xu, S., Venge, P., Lipocalins as biochemical markers of disease. Biochim. Biophys. Acta 2000, 1482, 298-307.
32. Steinhoff, J., Feddersen, A., Wood, W. G., Hoyer, J. et al., Glomerular proteinuria as an early sign of renal-transplant rejection. Clin. Nephrol. 1991, 35, 255-262.
33. Schaub, S., Wilkins, J. A., Antonovici, M., Krokhin, O. et al., Proteomic-based identification of cleaved urinary beta2-microglobulin as a potential marker for acute tubular injury in renal allografts. Am. J. Transplant. 2005, 5, 729-738.
34. Hampel, D. J., Sansome, C., Sha, M., Brodsky, S. et al., Toward proteomics in uroscopy: Urinary protein profiles after radiocontrast medium administration. J. Am. Soc. Nephrol. 2001, 12, 1026-1035.
35. Câmara, N. O., Silva, M. S., Nishida, S., Pereira, A. B. et al., Proximal tubular dysfunction is associated with chronic allograft nephropathy and decreased long-term renal-graft survival. Transplantation 2004, 78, 269-275.
36. Teppo, A. M., Honkanen, E., Finne, P., Törnroth, T. et al., Increased urinary excretion of alpha-1 microglobulin, at 6 months after transplantation is associated with urinary excretion of transforming growth factor beta-1 and indicates poor long term renal outcome. Transplantation 2004, 78, 719-724.
37. Spahr, C. S., Davis, M. T., McGinley, M. D., Robinson, J. H. et al., Towards defining the urinary proteome using liquid chromatography-tandem mass spectrometry. I. Profiling an unfractionated tryptic digest. Proteomics 2001, 1, 93-107.
38. Pieper, R., Gatlin, C. L., McGrath, A. M., Makusky, A. J. et al., Characterization of the human urinary proteome: A method for high-resolution display of urinary proteins an two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots. Proteomics 2004, 4, 1159-1174.
39. Smith, G., Barratt, D., Rowlinson, R., Nickson, J. et al., Development of a high-throughput method for preparing human urine for two-dimensional electrophoresis. Proteomics 2005, 5, 2315-2318.
40. Arikawa-Hirasawa, E., Watanabe, H., Takami, H., Hassell, J. R. et al., Perlecan is essential for cartilage and cephalic development. Nat. Genet. 1999, 23, 354-358.
41. Costell, M., Carmona, R., Gustafsson, E., Gonzalez-Iriarte, M. et al., Hyperplastic conotruncal endocardial cushions and transposition of great arteries in perlecan-null mice. Circ. Res. 2002, 91, 158-164.
42. Tran, P. K., Tran-Lundmark, K., Soininen, R., Tryggvason, K. et al., Increased intimal hyperplasia and smooth muscle cell proliferation in transgenic mice with heparan sulfate-deficient perlecan. Circ. Res. 2004, 94, 550-558.
43. Pillarisetti, S., Lipoprotein modulation of subendothelial heparan sulfate proteoglycans (perlecan) and atherogenicity. Trends Cardiovasc. Med. 2000, 10, 60-65.
44. Gonzalez, E. M., Reed, C. C., Bix, G., Fu, J. et al., BMP-1/ Tolloid-like metalloproteases process endorepellin, the angiostatic C-terminal fragment of perlecan. J. Biol. Chem. 2005, 280, 7080-7087.
45. Bonsib, S. M., Abul-Ezez, S. R., Ahmad, I., Young, S. M. et al., Acute rejection-associated tubular basement membrane defects and chronic allograft nephropathy. Kidney Int. 2000, 58, 2206-2214.